Bioveta, a. s. – Medical Department
The principal activity of the Medical Department, Human Division of Bioveta, Inc. company is the research and manufacture of pharmaceuticals for human use. The division products portfolio at the moment includes the nutritional supplements CANDIVAC, DENTIVAC PLUS, ACNEVAC, URIVAC and OLIMUNOVAC.
|
NEW PRODUCT – OLIMUNOVACOLIMUNOVAC has a positive effect on the immune system and helps to enhance the body’s general immunity, especially of the respiratory tract. OLIMUNOVAC may be used with advantage as a part of the measures to strengthen immunity in a period of increased occurrence of respiratory tract infections. It contains a dose for four months in one. |
|
|
|
|---|---|
|
CANDIVAC has a positive effect on the immune system and it helps to increase the immune defence of the organism, especially of the vaginal mucosa. |
DENTIVAC PLUS positively influences the immune system. It supports the immune defence of the organism, especially of the buccal cavity. |
|
|
|
|
ACNEVAC has a positive effect on the immune system. It supports the defence system of the organism, especially of the skin |
URIVAC has a positive effect on the immune system. It supports the defence system of the organism, especially of the urinary tract |
